A study found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new guidelines.

Type 2 diabetes (T2D) results from the cells’ insulin resistance, and to date, insulin therapy and diabetes medications targeting glycemic management have failed to reverse the increase in T2D ...

With Novo Nordisk’s Wegovy already in the market, Eli Lilly is stepping up its game with a patient-friendly pen device, ...

Patients received the FlexPen if they were randomized to the insulin pen group and prescribed any rapid-acting insulin (insulin lispro or insulin aspart) or the combination of 70% insulin aspart ...

Administration of insulin through pen devices in the ambulatory care setting has been shown to improve insulin regimen adherence and patient satisfaction. [5–9] Authors of a survey evaluating ...

The United States insulin pen market size was valued at USD 4.2 billion in 2024 and is projected to hit around USD 8.1 billion by 2033, growing at a CAGR of 6.9% during the forecast period 2025 to ...

The U.S. insulin pen market is set to grow from USD 4.2 billion in 2024 to USD 8.1 billion by 2033 at a 6.9% CAGR. Key growth drivers include advanced technology, increased awareness, and favorable ...

The U.S. insulin pen market is set to grow from USD 4.2 billion in 2024 to USD 8.1 billion by 2033 at a 6.9% CAGR. Key growth drivers include advanced technology, increased awareness, and ...

IL-1β alters the insulin sensitivity of AT by suppressing insulin signaling; exposure to IL-1β of murine and human adipocytes decreases insulin-stimulated glucose uptake and lipogenesis (Lagathu et al ...

CLEVELAND, OH, UNITED STATES, June 19, 2025 / EINPresswire.com / -- Diasome Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company advancing portal-hepatic targeted therapies for metabolic ...

Phase 2b OPTI-2 trial to assess liver-targeted insulin's ability to reduce hypoglycemia and improve postprandial control using Dexcom G7 CGM data< ...